miR-29a suppresses growth and migration of hepatocellular carcinoma by regulating CLDN1

被引:57
作者
Mahati, Shaya [1 ]
Xiao, Lei [1 ]
Yang, Ying [1 ]
Mao, Rui [1 ]
Bao, Yongxing [1 ]
机构
[1] Xinjiang Med Univ XJMU, Affiliated Hosp 1, Dept Tumor Ctr, 137 Liyushan St, Urumqi 830011, Peoples R China
关键词
Hepatocellular carcinoma (HCC); miR-29a; CLDN1; Migration; Cell growth; CELLS;
D O I
10.1016/j.bbrc.2017.03.110
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
CLDN1 (claudin1) is essential for intercellular junctions and has been reported to be involving in cell migration and metastasis, making it as an oncogene in various cancer types. However, the biological function roles and regulatory mechanisms of CLDN1 in hepatocellular carcinoma (HCC) are still not clarified. In this study, we found down-regulation of miR-29a and up-regulation of CLDN1 in HCC tissues and cell lines. Further found an inverse relation between the expressions of miR-29a and CLDN1 in HCC. Dual-luciferase reporter assay indicated that miR-29a regulated the expression of CLDN1 by binding to its 3' untranslated region (3'UTR). Knockdown of CLDN1 led to decrease in tumor cell growth and migration capacities in vitro and in vivo. While overexpression of miR-29a suppressed tumor growth and migration, these effects could be reversed by re-expressing CLDN1. Taken together, out data suggested that miR-29a may regulate tumor growth and migration by targeting CLDN1, providing promising therapeutic targets for HCC. (C) 2017 Published by Elsevier Inc.
引用
收藏
页码:732 / 737
页数:6
相关论文
共 20 条
[1]   Identification of Claudin 1 Transcript Variants in Human Invasive Breast Cancer [J].
Blanchard, Anne A. ;
Zelinski, Teresa ;
Xie, Jiuyong ;
Cooper, Steven ;
Penner, Carla ;
Leygue, Etienne ;
Myal, Yvonne .
PLOS ONE, 2016, 11 (09)
[2]   Management of Hepatocellular Carcinoma: An Update [J].
Bruix, Jordi ;
Sherman, Morris .
HEPATOLOGY, 2011, 53 (03) :1020-1022
[3]   Low levels of circulating microRNA-26a/29a as poor prognostic markers in patients with hepatocellular carcinoma who underwent curative treatment [J].
Cho, Hyo Jung ;
Kim, Soon Sun ;
Nam, Ji Sun ;
Kim, Jai Keun ;
Lee, Jei Hee ;
Kim, Bohyun ;
Wang, Hee Jung ;
Kim, Bong Wan ;
Lee, Jung-Dong ;
Kang, Dae Yong ;
Kim, Ji Hyun ;
Jae, Yang Min ;
Hwang, Jae Chul ;
Shin, Sung Jae ;
Lee, Kee Myung ;
Cho, Sung Won ;
Cheong, Jae Youn .
CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, 2017, 41 (02) :181-189
[4]   ADAM12-L is a direct target of the miR-29 and miR-200 families in breast cancer [J].
Duhachek-Muggy, Sara ;
Zolkiewska, Anna .
BMC CANCER, 2015, 15
[5]   RETRACTED: MiR-451 Promotes Cell Proliferation and Metastasis in Pancreatic Cancer through Targeting CAB39 (Retracted Article) [J].
Guo, Rende ;
Gu, Jianhua ;
Zhang, Zhibin ;
Wang, Yi ;
Gu, Chuan .
BIOMED RESEARCH INTERNATIONAL, 2017, 2017
[6]   Role of ADAM17 in invasion and migration of CD133-expressing liver cancer stem cells after irradiation [J].
Hong, SungWoo ;
Hur, Wonhee ;
Choi, Jung Eun ;
Kim, Jung-Hee ;
Hwang, Daehee ;
Yoon, Seung Kew .
ONCOTARGET, 2016, 7 (17) :23482-23497
[7]   Nm23H1 mediates tumor invasion in esophageal squamous cell carcinoma by regulation of CLDN1 through the AKT signaling [J].
Kuo, K-T ;
Chen, C-L ;
Chou, T-Y ;
Yeh, C-T ;
Lee, W-H ;
Wang, L-S .
ONCOGENESIS, 2016, 5 :e239-e239
[8]   Novel role of miR-29a in pancreatic cancer autophagy and its therapeutic potential [J].
Kwon, Jason J. ;
Willy, Jeffrey A. ;
Quirin, Kayla A. ;
Wek, Ronald C. ;
Korc, Murray ;
Yin, Xiao-Ming ;
Kota, Janaiah .
ONCOTARGET, 2016, 7 (44) :71635-71650
[9]   Negative feedback of miR-29 family TET1 involves in hepatocellular cancer (vol 31, pg 291, 2014) [J].
Lin, Li Li ;
Wang, Wei ;
Hu, ZhaoYang ;
Wang, Li Wen ;
Chang, Jing ;
Qian, HanGuang .
MEDICAL ONCOLOGY, 2015, 32 (03)
[10]   Claudin-1 overexpression in intestinal epithelial cells enhances susceptibility to adenamatous polyposis coli-mediated colon tumorigenesis [J].
Pope, Jillian L. ;
Ahmad, Rizwan ;
Bhat, Ajaz A. ;
Washington, Mary K. ;
Singh, Amar B. ;
Dhawan, Punita .
MOLECULAR CANCER, 2014, 13